This may explain the lower-than-expected classification accuracy of SPARE-AD2 at separating between the two groups and may have limited the correlation between SPARE-AD2 and Alzheimer’s disease-related molecular measurements. The gene discussed is APOE; the disease is Alzheimer disease.